Welcome to the InfoSci Platform
Antimicrobial Consumption and Multidrug Resistant Organisms in Intensive Care Units: Lessons from Saudi Arabia

Antimicrobial Consumption and Multidrug Resistant Organisms in Intensive Care Units: Lessons from Saudi Arabia

Fouad Farouk Jabri
Copyright: © 2017 |Pages: 32
ISBN13: 9781522516743|ISBN10: 1522516743|EISBN13: 9781522516750
DOI: 10.4018/978-1-5225-1674-3.ch008
Cite Chapter Cite Chapter

MLA

Jabri, Fouad Farouk. "Antimicrobial Consumption and Multidrug Resistant Organisms in Intensive Care Units: Lessons from Saudi Arabia." Public Health and Welfare: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, IGI Global, 2017, pp. 151-182. https://doi.org/10.4018/978-1-5225-1674-3.ch008

APA

Jabri, F. F. (2017). Antimicrobial Consumption and Multidrug Resistant Organisms in Intensive Care Units: Lessons from Saudi Arabia. In I. Management Association (Ed.), Public Health and Welfare: Concepts, Methodologies, Tools, and Applications (pp. 151-182). IGI Global. https://doi.org/10.4018/978-1-5225-1674-3.ch008

Chicago

Jabri, Fouad Farouk. "Antimicrobial Consumption and Multidrug Resistant Organisms in Intensive Care Units: Lessons from Saudi Arabia." In Public Health and Welfare: Concepts, Methodologies, Tools, and Applications, edited by Information Resources Management Association, 151-182. Hershey, PA: IGI Global, 2017. https://doi.org/10.4018/978-1-5225-1674-3.ch008

Export Reference

Mendeley
Favorite

Abstract

Improper antimicrobial use and bacterial resistance can affect an entire community, threaten public health and create economic burdens and ecological consequences on societies. This chapter discusses the importance of counteracting this public health issue. In Saudi Arabia, the appropriate use of antimicrobial agents is of particular concern. The prescribing of broad-spectrum antimicrobials in hospital settings is not highly restricted, and antimicrobials are available over the counters in pharmacies. This unwise use provides a scenario for the emergence of bacterial resistance and subsequent public health concerns. In addition, there is a lack of representative epidemiological research on antimicrobial consumption and quantitative data linking consumption to the incidence of resistance. This chapter illustrates that the implementation and the success of the strategies that monitor and control antimicrobial consumption depend on the availability of information about the extent and patterns of antimicrobial consumption. It demonstrates the potentials and recommendations on obtaining antimicrobial consumption data using defined daily dose as a unit of measurement in Saudi hospital settings.

Request Access

You do not own this content. Please login to recommend this title to your institution's librarian or purchase it from the IGI Global bookstore.